kabutan

YOMEISHU SEIZO CO.,LTD.(2540) Summary

2540
TSE Prime
YOMEISHU SEIZO CO.,LTD.
4,290
JPY
+30
(+0.70%)
Jan 29, 1:32 pm JST
27.99
USD
Jan 28, 11:39 pm EST
Result
PTS
outside of trading hours
4,281
Jan 29, 1:32 pm JST
Summary Chart Historical News Financial Result
PER
70.8
PBR
1.25
Yield
1.05%
Margin Trading Ratio
38.77
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
4,260 JPY 27.82 USD
Previous Close Jan 28
4,260 JPY 27.91 USD
High Jan 29, 12:58 pm
4,295 JPY 28.08 USD
Low Jan 29, 9:03 am
4,220 JPY 27.55 USD
Volume
21,300
Trading Value
0.09B JPY 0.62M USD
VWAP
4258.57 JPY 27.83 USD
Minimum Trading Value
429,000 JPY 2,799 USD
Market Cap
0.07T JPY 0.46B USD
Number of Trades
94
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Mid
1-Year Average
143
1-Year High Dec 30, 2025
1,735
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 8,500 253,000 29.76
Jan 16, 2026 10,900 280,600 25.74
Jan 9, 2026 13,200 322,200 24.41
Dec 26, 2025 7,200 446,300 61.99
Dec 19, 2025 7,600 441,600 58.11
Company Profile
YOMEISHU SEIZO CO.,LTD. is the leading manufacturer of medicinal liquor, established in 1602. The company develops the "Yomeishu" brand. Its largest shareholder is Taisho Pharmaceutical.
Sector
Foods
YOMEISHU SEIZO CO.,LTD. primarily engages in the manufacturing and sales of "Yomeishu" and other alcoholic beverages and food products both domestically and internationally. Additionally, the company operates solar power generation for electricity sales, real estate leasing, and restaurant management. In the Yomeishu-related business, the company manufactures and sells alcoholic beverages and food products, including its flagship product "Yomeishu," in Japan and overseas. The company has also positioned its related businesses under the concept of "Expanding the Circle of Healthy Living," which it calls the "Kurasowa" business. This includes multi-faceted retail and service operations such as store management in directly-operated commercial facilities, restaurant management, mail-order sales, and external sales through other companies' distribution channels. YOMEISHU SEIZO CO.,LTD. is an equity-method affiliate of Taisho Pharmaceutical Holdings.